653
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett’s esophagus, dysplasia and adenocarcinoma

, , , , &
Article: e1127495 | Received 29 Sep 2015, Accepted 25 Nov 2015, Published online: 29 Apr 2016

References

  • Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335–76; PMID:12524386; http://dx.doi.org/10.1146/annurev.immunol.21.120601.141126
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646–74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
  • Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 2011; 108 Suppl 1:4607–14; PMID:20826446; http://dx.doi.org/10.1073/pnas.1000092107
  • Coste I, Le Corf K, Kfoury A, Hmitou I, Druillennec S, Hainaut P, Eychene A, Lebecque S, Renno T. Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. J Clin Invest 2010; 120:3663–7; PMID:20941850; http://dx.doi.org/10.1172/JCI42771
  • Takala H, Kauppila JH, Soini Y, Selander KS, Vuopala KS, Lehenkari PP, Saarnio J, Karttunen TJ. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun 2011; 3:631–8; PMID:21876325; http://dx.doi.org/10.1159/000329115
  • Kauppila JH, Takala H, Selander KS, Lehenkari PP, Saarnio J, Karttunen TJ. Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology 2011; 59:643–9; PMID:22014045; http://dx.doi.org/10.1111/j.1365-2559.2011.03991.x
  • Huhta H, Helminen O, Kauppila JH, Takala H, Metsikko K, Lehenkari P, Saarnio J, Karttunen T. Toll-like receptor 9 expression in the natural history of Barrett mucosa. Virchows Arch 2015; 467:9–18; PMID:25838081; http://dx.doi.org/10.1007/s00428-015-1770-3
  • Kauppila JH, Karttunen TJ, Saarnio J, Nyberg P, Salo T, Graves DE, Lehenkari PP, Selander KS. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS 2013; 121:511–22; PMID:23082743; http://dx.doi.org/10.1111/apm.12016
  • Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, Wang H. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17:3745–51; PMID:21990957; http://dx.doi.org/10.3748/wjg.v17.i32.3745
  • Kauppila JH, Selander KS. Toll-like receptors in esophageal cancer. Front Immunol 2014; 5:200; PMID:24847326; http://dx.doi.org/10.3389/fimmu.2014.00200
  • Helminen O, Huhta H, Takala H, Lehenkari PP, Saarnio J, Kauppila JH, Karttunen TJ. Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia. Virchows Arch 2014; 464:11–8; PMID:24221343; http://dx.doi.org/10.1007/s00428-013-1505-2
  • Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, Hogaboam CM, Kunkel SL. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205:2609–21; PMID:18838547; http://dx.doi.org/10.1084/jem.20081370
  • Uehara A, Fujimoto Y, Fukase K, Takada H. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 2007; 44:3100–11; PMID:17403538; http://dx.doi.org/10.1016/j.molimm.2007.02.007
  • Lim DM, Wang ML. Toll-like receptor 3 signaling enables human esophageal epithelial cells to sense endogenous danger signals released by necrotic cells. Am J Physiol Gastrointest Liver Physiol 2011; 301:G91–9; PMID:21474651; http://dx.doi.org/10.1152/ajpgi.00471.2010
  • Verbeek RE, Siersema PD, Ten Kate FJ, Fluiter K, Souza RF, Vleggaar FP, Bus P, van Baal JW. Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression. J Gastroenterol 2014; 49:1121–34; PMID:23955118; http://dx.doi.org/10.1007/s00535-013-0862-6
  • Fernandez-Garcia B, Eiro N, Gonzalez-Reyes S, Gonzalez L, Aguirre A, Gonzalez LO, Del Casar JM, García-Muñiz JL, Vizoso FJ. Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer. J Immunother 2014; 37:77–83; PMID:24509170; http://dx.doi.org/10.1097/CJI.0000000000000016
  • Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303:1529–31; PMID:14976261; http://dx.doi.org/10.1126/science.1093616
  • Li L, Cheng FW, Wang F, Jia B, Luo X, Zhang SQ. The activation of TLR7 regulates the expression of VEGF, TIMP1, MMP2, IL-6, and IL-15 in Hela cells. Mol Cell Biochem 2014; 389:43–9; PMID:24347177; http://dx.doi.org/10.1007/s11010-013-1925-y
  • Kawai T, Akira S. Antiviral signaling through pattern recognition receptors. J Biochem 2007; 141:137–45; PMID:17190786; http://dx.doi.org/10.1093/jb/mvm032
  • Yu H, Wang Z, Sun G, Yu Y. Recognition of nucleic acid ligands by toll-like receptors 7/8: importance of chemical modification. Curr Med Chem 2012; 19:1365–77; PMID:22204348; http://dx.doi.org/10.2174/092986712799462603
  • Brameier M, Krings A, MacCallum RM. NucPred–predicting nuclear localization of proteins. Bioinformatics 2007; 23:1159–60; PMID:17332022; http://dx.doi.org/10.1093/bioinformatics/btm066
  • Lee BL, Barton GM. Trafficking of endosomal Toll-like receptors. Trends Cell Biol 2014; 24:360–9; PMID:24439965; http://dx.doi.org/10.1016/j.tcb.2013.12.002
  • Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 2012; 109:E2110–6; PMID:22753494; http://dx.doi.org/10.1073/pnas.1209414109
  • Roberts TC. The MicroRNA biology of the mammalian nucleus. Mol Ther Nucleic Acids 2014; 3:e188; PMID:25137140; http://dx.doi.org/10.1038/mtna.2014.40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.